End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.26 CNY | 0.00% | -7.67% | +12.41% |
Apr. 25 | Intco Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Intco Medical Technology Co., Ltd. Proposes Final Dividend for 2023 | CI |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.41% | 2.35B | - | A- | |
-29.43% | 3.14B | B- | ||
-18.39% | 2.47B | C+ | ||
+41.48% | 2.14B | B | ||
-1.23% | 2.03B | - | ||
+40.00% | 1.63B | B | ||
+5.74% | 1.34B | - | ||
+48.11% | 1.29B | C | ||
+9.30% | 1.19B | - | ||
+14.26% | 1.12B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 300677 Stock
- Ratings Intco Medical Technology Co., Ltd.